Pharmafile Logo

Peter Impey

- PMLiVE

Blind date: client-agency relationships

Thanks to today’s business pressures, ‘chemistry’ – once seen as the bedrock of client-agency relationships – has been sidelined in favour of increasingly complex RFIs that form a wedge between...

- PMLiVE

Communicating clearly: using PowerPoint properly

How to design and use data slides that really add to your presentation.

INC Research appoints new EVP, APAC

Garth Tierney co-founded Australian CRO Trident Clinical Research

- PMLiVE

Bayer pins hopes on five potential blockbusters

Riociguat, alpharadin, Stivarga, Eylea, and Xarelto expected to reach sales of €5.5bn by 2015

- PMLiVE

Depot Abilify approval in US buoys Lundbeck and Otsuka

FDA licences the once-monthly version of Lundbeck's blockbuster schizophrenia drug

Social media crisis management in healthcare

In a guest blog Uri Goren outlines a crisis toolkit for pharma

Novartis building

Novartis’ Ilaris cleared for gouty arthritis in EU

First biologic drug approved for condition in Europe

- PMLiVE

Boehringer Ingelheim selects Republica as first US agency of record

Cross-cultural marketing agency wins US business for the pharma company's communications strategy

- PMLiVE

The Leukemia & Lymphoma Society launches fundraising campaign in US

Charity’s $5m campaign intended to increase donations in search for cure

- PMLiVE

Lundbeck’s alcohol dependency drug approved in Europe

Selincro is the first drug approved to reduce alcohol consumption

- PMLiVE

Ipsen appoints Christel Bories as deputy CEO

Has senior experience in several industries

- PMLiVE

Fitness first: How pharma can get in shape for the future

As the market changes, existing capabilities become useless and new ones become essential. Professor Brian D Smith describes how pharma companies become fit for the future

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links